---
figid: PMC6288394__fimmu-09-02869-g0001
figlink: /pmc/articles/PMC6288394/figure/F1/
number: Figure 1
caption: Summary of the potential mechanisms of vaccine NSEs. (A) The top half illustrates
  adaptive mechanisms. Cross-reactive TCRs and antibodies. Lymphocyte antigen receptors
  recognize similar epitopes from different antigens. Bystander effect. Bystander
  activation of pre-existing effector or memory cells occurs via changes in the cytokine
  environment. Classical cell-mediated immunity. Adaptive immune cells potentiate
  the non-specific activity of innate cells in classical cell-mediated immunity. (B)
  The bottom half illustrates pathways of trained immunity. Primary stimulus of BCG.
  PRR signaling leads to TF activation, which then recruits chromatin modifiers to
  genes of interest. This stimulus also activate the autophagy and NOD2 signaling
  pathway. Upregulation of the Akt/mTOR pathway alters metabolite levels that regulate
  chromatin-modifying enzymes. Heterologous secondary stimulus. Epigenetic changes
  within innate cells after training act as de novo enhancers to boost the immune
  response against a secondary challenge.
pmcid: PMC6288394
papertitle: 'Non-specific Effects of Vaccines Illustrated Through the BCG Example:
  From Observations to Demonstrations.'
reftext: Deeva Uthayakumar, et al. Front Immunol. 2018;9:2869.
pmc_ranked_result_index: '36946'
pathway_score: 0.8783737
filename: fimmu-09-02869-g0001.jpg
figtitle: Summary of the potential mechanisms of vaccine NSEs
year: '2018'
organisms: Homo sapiens
ndex: 37abc8a5-df1a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6288394__fimmu-09-02869-g0001.html
  '@type': Dataset
  description: Summary of the potential mechanisms of vaccine NSEs. (A) The top half
    illustrates adaptive mechanisms. Cross-reactive TCRs and antibodies. Lymphocyte
    antigen receptors recognize similar epitopes from different antigens. Bystander
    effect. Bystander activation of pre-existing effector or memory cells occurs via
    changes in the cytokine environment. Classical cell-mediated immunity. Adaptive
    immune cells potentiate the non-specific activity of innate cells in classical
    cell-mediated immunity. (B) The bottom half illustrates pathways of trained immunity.
    Primary stimulus of BCG. PRR signaling leads to TF activation, which then recruits
    chromatin modifiers to genes of interest. This stimulus also activate the autophagy
    and NOD2 signaling pathway. Upregulation of the Akt/mTOR pathway alters metabolite
    levels that regulate chromatin-modifying enzymes. Heterologous secondary stimulus.
    Epigenetic changes within innate cells after training act as de novo enhancers
    to boost the immune response against a secondary challenge.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR8
  - TLR9
  - TLR7
  - AKT1
  - AKT2
  - IL1B
  - AKT3
  - TRB
  - NFKB1
  - NFKB2
  - RELB
  - RELA
  - FOSL1
  - FOS
  - REL
  - JUNB
  - MTOR
  - NOD2
  - TRG
  - TRA
  - TLR4
  - TRD
  - NELFCD
  - TLR5
  - TLR6
  - JUND
  - JUN
  - IL6
  - FOSB
  - TLR2
  - TLR10
  - TLR3
  - TLR1
  - FOSL2
  - TNF
  - TCR
  - Cholesterol
  - mevalonate
  - Citrate
  - TSA
  - Cancer
genes:
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IL-1B,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: Akt/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NOD2
  symbol: NOD2
  source: hgnc_symbol
  hgnc_symbol: NOD2
  entrez: '64127'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: Th1/17
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: TNFA,IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR)
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: (NFKB,STATS,AP-1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: TNFA,IL-6
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: mevalonate
  source: MESH
  identifier: D008798
- word: Citrate
  source: MESH
  identifier: C102006
- word: TSA
  source: MESH
  identifier: C070842
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
